Stocks and Finance

Alexion Pharmaceuticals

Alexion Pharmaceuticals 3/22/2012

07:39 : Goldman Sachs reiterates a Conviction Buy rating on Alexion Pharmaceuticals - Goldman Sachs reiterates a Conviction Buy rating on Alexion Pharmaceuticals (ALXN) and adds $13 to take its price target on shares to $105. The firm sees a clear win for Alexion off of published studies ...
Source : seekingalpha-com

Alexion Pharmaceuticals 2/9/2012

14:38 : Alexion Pharmaceuticals ([[ALXN]] +4.3%) trades higher after its Q4 beat ... - Alexion Pharmaceuticals (ALXN +4.3%) trades higher after its Q4 beat estimates across the board earlier today. Revenue jumped 45% Y/Y on higher overall net product sales, particularly in its blood disease drug Soliris with ...
Source : seekingalpha-com

Alexion Pharmaceuticals 7/8/2011

12:37 : UBS cuts estimates on Alexion Pharmaceuticals ([[ALXN]] +3.1%), and lowers - UBS cuts estimates on Alexion Pharmaceuticals (ALXN +3.1%), and lowers its price target to $53 from $55, keeping a Neutral rating on the firm. Shares are outgaining all issues listed on the NASDAQ-100. Post your ...
Source : seekingalpha-com
actualidad Alexion Pharmaceuticals -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts